Literature DB >> 12475795

Proinsulin 2 knockout NOD mice: a model for genetic variation of insulin gene expression in type 1 diabetes.

Danièle Dubois-Lafforgue1, Laurent Mogenet, Karine Thébault, Jacques Jami, Patricia Krief, Christian Boitard.   

Abstract

Insulin is a major disease determinant in type 1 diabetes, type 2 diabetes, and related disorders. The role of variations in the expression of the insulin gene has been proposed in genetic susceptibility to the three pathological conditions in humans. In contrast to humans, rodents express two proinsulin isoforms. One isoform, proinsulin 1, is expressed exclusively in islets. The second, proinsulin 2, is expressed in islets and in other tissues, especially the thymus. We took advantage of the expression of these two isoforms to introduce a null proinsulin 2 allele in NOD mice and to evaluate the consequence of a variation of proinsulin 2 gene expression on the development of type 1 diabetes on the NOD genetic background. Heterozygote NOD mutant mice carrying a null proinsulin 2 mutation showed an increased incidence of type 1 diabetes at successive backcross generations. Plasma glucose and insulin levels were identical in prediabetic mutant and in wild-type mice at 4 weeks of age. Variation in insulin gene expression is hypothesized to interfere with diabetes development at both the islet and the thymus level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475795     DOI: 10.2337/diabetes.51.2007.s489

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  3 in total

1.  Ectopic expression of peripheral-tissue antigens in the thymic epithelium: probabilistic, monoallelic, misinitiated.

Authors:  Jennifer Villaseñor; Whitney Besse; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-03       Impact factor: 11.205

2.  2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia.

Authors:  C M Kiekhaefer; B Weber; M Huggins; C Gorichanaz; J A Nehring; H F DeLuca
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

Review 3.  Type 1 diabetes: primary antigen/peptide/register/trimolecular complex.

Authors:  Tomasz Sosinowski; George S Eisenbarth
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.